Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reactions
Center for Molecular Medicine First Midwest-Based Lab Offering Roche Test to Help Predict Drug Performance & Improve Safety
June 26th, 2007
The Center for Molecular Medicine (CMM) announced it is the first Midwest-based laboratory to offer the FDA-approved AmpliChip(R) CYP450 Test to physicians and hospitals. This genomics-based, FDA-approved clinical laboratory test provides physicians information that may be used to help determine a patient's unique ability or inability to metabolize a large variety of prescription drugs. AmpliChip CYP450 test results may be used by physicians to make more rational drug prescription decisions, reduce "trial and error" prescription and dosing and guard against dangerous and expensive adverse drug reactions. Reports from the Institute of Medicine and...
Source: Drug Law Weekly (2007-06-26)
|
